Back
Neurocrine Biosciences Stock Price Chart
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
NBIX
Neurocrine Biosciences
Last Price:
118.32
Seasonality Move:
9.9%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing slight selling pressure.
Neurocrine Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.13 | Sell |
| 20-day SMA: | 128.4 | Sell |
| 50-day SMA: | 139.44 | Sell |
| 200-day SMA: | 136.34 | Sell |
| 8-day EMA: | 121.75 | Sell |
| 20-day EMA: | 127.22 | Sell |
| 50-day EMA: | 134.41 | Sell |
| 200-day EMA: | 133.06 | Sell |
Neurocrine Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.08 | Sell |
| Relative Strength Index (14 RSI): | 32.31 | Sell |
| Chaikin Money Flow: | -385962 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (118.79 - 145.97) | Sell |
| Bollinger Bands (100): | (129.79 - 147.61) | Sell |
Neurocrine Biosciences Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences Stock
Is Neurocrine Biosciences Stock a Buy?
- Neurocrine Biosciences share price is 120.46 while NBIX 8-day simple moving average is 121.13, which is a Sell signal.
- The stock price of NBIX is 120.46 while Neurocrine Biosciences 20-day SMA is 128.40, which makes it a Sell.
- Neurocrine Biosciences 50-day simple moving average is 139.44 while NBIX share price is 120.46, making it a Sell technically.
- NBIX stock price is 120.46 and Neurocrine Biosciences 200-day simple moving average is 136.34, creating a Sell signal.
NBIX Technical Analysis vs Fundamental Analysis
Sell
41
Neurocrine Biosciences (NBIX)
is a Sell
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a Sell
The current Neurocrine Biosciences [NBIX] share price is $120.46. The Score for NBIX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Neurocrine Biosciences Stock Info
Market Cap:
12.16B
Price in USD:
120.46
Share Volume:
784.37K
Neurocrine Biosciences 52-Week Range
52-Week High:
157.98
52-Week Low:
103.63
Sell
41
Neurocrine Biosciences (NBIX)
is a Sell
Neurocrine Biosciences Share Price Forecast
-
What is the Neurocrine Biosciences stock price today?
The Neurocrine Biosciences stock price is 120.46 USD today. -
Will NBIX stock go up or go down?
Neurocrine Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Neurocrine Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences is overvalued.
Is Neurocrine Biosciences Stock a Buy?
- Neurocrine Biosciences share price is 120.46 while NBIX 8-day exponential moving average is 121.75, which is a Sell signal.
- The stock price of NBIX is 120.46 while Neurocrine Biosciences 20-day EMA is 127.22, which makes it a Sell.
- Neurocrine Biosciences 50-day exponential moving average is 134.41 while NBIX share price is 120.46, making it a Sell technically.
- NBIX stock price is 120.46 and Neurocrine Biosciences 200-day simple moving average is 133.06, creating a Sell signal.
Fundamental Analysis of Neurocrine Biosciences
Is Neurocrine Biosciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.36 per share, an increase this year of $2.34 per share, and an increase next year of $1.55 per share.
Technical Analysis of Neurocrine Biosciences
Should I short Neurocrine Biosciences stock?
- NBIX Moving Average Covergence Divergence (MACD) indicator is -6.08, suggesting Neurocrine Biosciences is a Sell
- Neurocrine Biosciences Relative Strength Index (RSI) is 32.31, which suggest Neurocrine Biosciences is oversold
- The Bollinger Bands (25) for Neurocrine Biosciences is (118.79 - 145.97), which suggest Neurocrine Biosciences is a Sell
- The Bollinger Bands (100) for Neurocrine Biosciences is (129.79 - 147.61), which suggest Neurocrine Biosciences is a Sell
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.